1. Japan Stocks

  2. •

    Process industries

  3. •

    Pulp & paper
Nichiban Co., Ltd.

Nichiban Co., Ltd.

TTSE:4218
1,878.00
JPY
-4.00
(-0.21%)
37.86BMarket Cap
Nov 12Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
1,940.85
1,924.8
2,048.8
2,130.18
2,231.18
2,288.31
2,126.46
1,995.05
2,081.64
2,203.2
2,282.68
2,430.18
2,481.34
- -
Basic EPS, GAAP
47.72
63.26
88.15
149.93
151.15
154.09
84.5
65.15
87.3
114.66
89
96.26
81.22
- -
Free Cash Flow per Basic Share
45.55
26.97
118.17
-76.77
-88.75
37.69
207.9
155.78
45.27
1.06
-28.11
113.36
16.13
- -
Dividend per Share
11.97
12.01
15.97
21.96
35.95
39.91
37.93
33.01
29.97
30.08
35.12
34.94
35.01
- -
Book Value per Share
1,232.64
1,297.17
1,357.73
1,484.58
1,607.76
1,760.45
1,796.03
1,837.54
1,880.16
1,969.86
2,049.08
2,121.38
2,196.33
2,196.33
Tangible Book Value per Share
1,222.66
1,289.89
1,344.41
1,469.72
1,593.57
1,744.38
1,773.2
1,791.5
1,818.91
1,910.04
2,000.68
2,089.55
2,170.81
2,170.81
Basic Weighted Avg Shares
21
21
21
21
21
21
21
21
21
21
21
20
20
20
Sales/Revenue/Turnover
40,225
39,892
42,461
44,145
46,234
47,417
44,063
41,340
43,134
45,560
46,859
49,457
50,470
- -
Operating Margin (%)
4.45
5.42
7.92
9.19
9.56
7.77
6.75
4.84
5.68
3.53
4.42
5.23
4.5
- -
Depreciation Expense
1,787
1,385
1,603
1,792
1,960
2,327
2,352
2,342
2,545
2,757
2,795
3,145
2,843
- -
Net Income, GAAP
989
1,311
1,827
3,107
3,132
3,193
1,751
1,350
1,809
2,371
1,827
1,959
1,652
- -
Effective Tax Rate (%)
43.2
39.62
34.27
26.4
28.62
29.85
29.55
28.95
29.32
30.87
19.58
25.42
22.21
- -
Profit Margin (%)
2.46
3.29
4.3
7.04
6.77
6.73
3.97
3.27
4.19
5.2
3.9
3.96
3.27
- -
Working Capital
17,227
17,751
18,160
16,050
13,730
14,968
19,246
19,575
19,543
20,095
21,759
22,716
21,984
21,984
LT Debt
2,507
2,438
2,326
2,251
2,170
137
2,104
2,069
2,094
2,090
2,082
2,080
108
108
Total Equity
25,547
26,884
28,138
30,764
33,315
36,479
37,216
38,076
38,959
40,602
41,702
43,186
44,324
44,324
Return on Invested Capital (%)
3.59
4.45
7.14
9.1
8.97
6.81
5.31
3.54
4.17
2.59
3.82
4.28
3.81
- -
Return on Capital (%)
3.63
4.62
6.14
9.79
9.17
8.65
4.55
3.44
4.46
5.68
4.29
4.46
3.67
- -
Return on Common Equity (%)
3.93
5
6.64
10.55
9.78
9.15
4.75
3.59
4.7
5.96
4.44
4.62
3.78
- -

Capital Structure

JPY

•

in mil. unless spec.
Jun'26
Sep'26
Mar'26
ST Debt
- -
2,000
2,063
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
172
108
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
20
20
20
Market Capitalization
39,392
40,206
37,859

Working Capital

JPY

•

in mil. unless spec.
Jun'26
Sep'26
Mar'26
Total Current Assets
- -
40,079
39,191
Cash, Cash Equivalents & STI
- -
15,125
14,128
Accounts Receivable, Net
- -
8,725
9,017
Inventories
- -
10,166
9,303
Total Current Liabilities
- -
18,586
17,207
Payables & Accruals
- -
- -
- -
ST Debt
- -
2,000
2,063
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.69%
3.09%
2.64%
Free Cash Flow
-334.23%
-695.39%
-85.78%
Net Income, GAAP
3.84%
6.74%
-15.67%
Sales/Revenue/Turnover
1.84%
4.08%
2.05%
Total Cash Common Dividend
9.99%
1.12%
0.14%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
10,916
11,542
13,046
11,355
46,859
2025
- -
- -
- -
- -
49,457
2026
- -
- -
- -
- -
50,470

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
13.63
7.33
46.7
21.42
89
2025
- -
- -
- -
- -
96.26
2026
- -
- -
- -
- -
81.22

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
35.12
2025
- -
- -
- -
- -
34.94
2026
- -
- -
- -
- -
35.01

Company Description

Company Profile APIChatGPT
CEO
Toshiaki Takatsu
Full Time Employees
1,271
Sector
Process industries
Industry
Pulp & paper
Address
5-1, Kojimachi Tokyo TY Japan 102 8811
IPO Date
Oct 2, 1961
Website
nichiban.co.jp
Similar Companies
International Paper Company (NYSE:IP)
JK Paper Limited (NSE:JKPAPER)
Avery Dennison Corporation (NYSE:AVY)
Alkim Kagit Sanayi ve Ticaret A.S. (BIST:ALKA)
Alkim Alkali Kimya A.S. (BIST:ALKIM)
Suzano S.A. (B3:SUZB3)
Business
Nichiban Co., Ltd. manufactures and sells adhesive tapes, medical products, and related adhesives primarily in Japan, Asia, and Europe. Founded in January 1918 and headquartered in Tokyo, Japan, the company offers a broad portfolio of products including medical tapes such as surgical tapes, wound care dressing tapes like CARELEAVES, post-operative care tapes, cornea protection tapes, hemostatic bandages, and first-aid bandages; sports medical products comprising battlewin taping tapes, kinesiology tapes, underwraps, scissors, and bags; healthcare items like anti-inflammatory patches, pain relief plasters such as ROIHI-TSUBOKO, foot care and corn plasters like SPEEL-KO, and waterproof films; industrial tapes for packaging, carton sealing, agriculture, automotive, construction, electronics, and machinery applications including masking tapes, PVC tapes, and cloth adhesive tapes; and stationery and office supplies such as CELLOTAPE cellulose tapes, double-sided tapes, adhesive transfer tapes, book binding tapes, and bag sealers. The company operates through segments including healthcare for general consumers and professionals, medical products for hospitals, office and home stationery, industrial applications, and overseas development via affiliates like Union Thai Nichiban Co., Ltd. in Thailand, exporting to approximately 50 countries with consolidated sales of 49.4 billion yen as of fiscal year 2025. In recent developments, Nichiban launched its new medium-term management plan "CREATION 2026" in April 2024, emphasizing innovation creation, globalization, and a new business portfolio to achieve the "NICHIBAN GROUP 2030 VISION" of global contributions; reported mixed first-half fiscal 2026 results with 1.6% net sales growth to support a full-year forecast of 4.1% sales increase and 16% operating profit rise; delayed its head office relocation to November 2025; and maintains a strong equity ratio of 64.1% while pursuing B2B and B2C expansions in hospital products and customer feedback-driven development.